H.PIO Co (357230) Fair Value & Analysis
Consumer Non-Cyclicals · KR · Market cap 87.4B KRW
Fair value as of: Jul 21, 2026
From 15 valuation models · updated 21 days ago
Share price +6.2% over the past month.
A solid business, screening 75% undervalued on our models.
What matters now
- The price is below even our cautious bear case (2,866 KRW). The market is more pessimistic than our downside scenario.
- Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (2,866 KRW to 5,315 KRW) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range 1,963 KRW – 8,556 KRW · fair‑value band 2,866 KRW – 5,315 KRW · the 2,330 KRW price screens below the 4,089 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
H.PIO Co (357230) currently trades at 2,330 KRW, while our model-based Fair Value estimate is 4,089 KRW, implying the stock looks roughly 75.5% undervalued today. The Quality Score stands at 54/100 (solid quality), in the Consumer Non-Cyclicals sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, H.PIO Co generated revenue of 190B KRW at a net margin of 7.0%. Revenue grew 38.3% year over year. Fundamentals as of Jul 21, 2026
Our scenario range runs from 2,866 KRW (bear case) to 5,315 KRW (bull case); at 2,330 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 29% below its 52-week high and 7% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at 7% fair-value upside, at 75%, 357230 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: DCF Models (7,539 KRW) versus Asset-Based (2,575 KRW). Highest evidence: Residual Income (76).
Notify me when 357230 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 36
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
H.PIO Co., Ltd. manufactures and sells health functional foods worldwide. It offers dietary and mixed vitamin supplements. The company was founded in 2012 and is headquartered in Seoul, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
H.PIO Co reported revenue of 258B KRW in FY2025 versus 159B KRW in FY2021, a compound +12.8%/yr. Reported net income was 8.4B KRW in FY2025, compounding −15.4%/yr from FY2021.
Watch 357230: get an alert when its fair value changes →
Peer Group
Food & Tobacco · 19 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Food & Tobacco stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| FB FB | 49.00 PHP | 49.03 PHP | +0% |
| URC URC | 61.20 PHP | 47.86 PHP | -22% |
| CNPF CNPF | 32.50 PHP | 64.84 PHP | +100% |
| 540743 540743 | ₹556.65 | ₹616.73 | +11% |
| DNL DNL | 3.64 PHP | 3.43 PHP | -6% |
| RFM RFM | 5.41 PHP | 8.87 PHP | +64% |
| AXLM AXLM | 2.70 PHP | 2.89 PHP | +7% |
| EASY BIO,Inc. 353810 | 6,120 KRW | 17,633 KRW | +188% |
| Helixmith Co 084990 | 3,315 KRW | 823.10 KRW | -75% |
| LFM LFM | 26.60 PHP | 7.12 PHP | -73% |
Compare H.PIO Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is H.PIO Co (357230) overvalued or undervalued?
What is the fair value of 357230?
What is the quality score of 357230?
What is the revenue of H.PIO Co (357230)?
What is the net profit margin of 357230?
Does H.PIO Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track H.PIO Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.